Neuland Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Neuland Laboratories has a total shareholder equity of ₹12.8B and total debt of ₹825.1M, which brings its debt-to-equity ratio to 6.4%. Its total assets and total liabilities are ₹18.3B and ₹5.5B respectively. Neuland Laboratories's EBIT is ₹4.0B making its interest coverage ratio 141.6. It has cash and short-term investments of ₹875.8M.
Key information
6.4%
Debt to equity ratio
₹825.07m
Debt
Interest coverage ratio | 141.6x |
Cash | ₹875.75m |
Equity | ₹12.83b |
Total liabilities | ₹5.50b |
Total assets | ₹18.33b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524558's short term assets (₹9.2B) exceed its short term liabilities (₹4.3B).
Long Term Liabilities: 524558's short term assets (₹9.2B) exceed its long term liabilities (₹1.2B).
Debt to Equity History and Analysis
Debt Level: 524558 has more cash than its total debt.
Reducing Debt: 524558's debt to equity ratio has reduced from 33.1% to 6.4% over the past 5 years.
Debt Coverage: 524558's debt is well covered by operating cash flow (316.6%).
Interest Coverage: 524558's interest payments on its debt are well covered by EBIT (141.6x coverage).